To support further investment in research, development and innovation and start up new growth projects in Italy – these are the goals of a new six million-euro loan provided by Cassa Depositi e Prestiti to SIFI, a Sicily-based healthcare company engaged, for almost 90 years now, in the engineering, development, production and sale of innovative therapies for the treatment of eye diseases.
The financing will be invested in research and development projects for new surgical techniques and pharmaceuticals, including new therapies for the treatment of rare eye diseases, and in the purchase of new machinery and instrumentation to expand production lines.
Established in 1935 with the mission of improving patients’ quality of vision through meaningful innovation in eye care, SIFI today employs around 500 people around the globe, with a consolidated presence across the nation (two production facilities in Aci Sant’Antonio, Catania) and solid sales in major international markets. With direct operations in Spain, France, Romania, Mexico and Turkey, SIFI exports its products to as many as 40 countries worldwide.